INTERVET NOBILIS LIVE NEWCASTLE VACCINE V4

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

NEWCASTLE DISEASE STRAIN V-4 VIRUS

제공처:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

vaccine - Newcastle disease

약제 형태:

MISC. VACCINES OR ANTI SERA

구성:

NEWCASTLE DISEASE STRAIN V-4 VIRUS VACCINE-VIRAL Active 0.0 Undefined

패키지 단위:

10 Vials; 1000 doses; 10000doses; 2000 doses; 3000 doses; 4000 doses; 5000 doses; 6000 doses; 7000 doses; 8000 doses; 9000 doses; Per Vial

수업:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

치료 그룹:

POULTRY BROILERS (MEAT FOR HUMAN CONSUM) | CHICKENS | CHOOKS | MEAT BIRDS

치료 영역:

IMMUNOTHERAPY

치료 징후:

NEWCASTLE DISEASE

제품 요약:

Poison schedule: 0; Host/pest details: ; Poison schedule: 0; Withholding period: WHP: NIL; Host/pest details: POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [NEWCASTLE DISEASE]; For the prevention of virulent Newcastle disease in broiler chickens.Use of vaccine may be restricted - contact local Dept of Agriculture for details

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

INTERVET AUSTRALIA PTY LIMITED
INTERVET NOBILIS LIVE NEWCASTLE VACCINE V4
DC10A-82857526E128
63275/10
8701
COMPANY NAME:
PRODUCT NAME:
ELABEL APPLICATION NO:
APVMA APPROVAL NO:
P
LABEL NAME:
NOBILIS LIVE NEWCASTLE VACCINE V4
SIGNAL HEADINGS:
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
Contains : > 6.0 log10 EID50 per dose
Newcastle Disease Virus(NDV) Strain V4(living).
CLAIMS:
For the prevention of virulent Newcastle Disease in broiler chickens
NET CONTENTS:
10 x 1000 dose vials
10 x 2000 dose vials
10 x 3000 dose vials
10 x
4000 dose
vials
10 x 5000 dose vials
10 x 10000 dose vials
DIRECTIONS FOR USE:
Use of this vaccine may be restricted in your state or territory.
Contact your local
Department of Agriculture (or similar) for details.
RESTRAINTS:
CONTRAINDICATIONS:
PRECAUTIONS:
SIDE EFFECTS:
DOSAGE AND
ADMINISTRATION:
Dosage and Administration
Vaccinate healthy animals only.
Immunity: Intervet Newcastle Disease NDV4 vaccine,when administered at
7-14 days in
drinking water, induces levels of haemagglutination inhibition(HI)
antibodies in the blood as
10 x
6
000 dose vials
10 x
7
000 dose vials
10 x
8
000 dose vials
10 x
9
000 dose
vials RLP APPROVED
For Official Use Only
specified in the National Newcastle Disease Vaccination SOP, which is
based on scientific
literature that indicates protection against virulent ND at these
levels of antibody when
generated by live NDV vaccination
Vaccination Program
Drinking water: Dissolve the freeze dried pellet in enough drinking
water, with skim milk
powder (2.5% w/v) first included to neutralise any residual chlorine
to provide each 7-14
day-old chicken with one dose of vaccine over a 1-2 hour period.
Vaccination Procedure:
Preparation:
1. Check that all drinkers are working properly. Clean drinkers,
header tanks/medication
tanks and medication units- do not use detergent or disinfectant.
2. Calculate doses needed. ND vaccination is administered at 100%
rate-therefore each
bird must be allocated one full dose of vaccine.
3. Deprive the flock of water for 1-2 hours, d

제품 특성 요약

PRODUCT NAME: NDV4 LIVE VACCINE
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JANUARY, 2010
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
CHEMICAL NATURE:
Suspension of Newcastle Disease virus in saline.
TRADE NAME:
NDV4 LIVE VACCINE
RECOMMENDED USE:
For prevention of virulent Newcastle Disease in broiler chickens.
APVMA NO:
63275
CREATION DATE:
January, 2010
THIS VERSION ISSUED:
January, 2010
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S23, S25. Do not breathe mists. Avoid contact with eyes.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
No specific data. Expected to be white to off white suspension.
ODOUR:
No specific data; expected to be almost odourless.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. In addition
product is unlikely to
cause any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT TERM EXPOSURE
: This product may be mildly irritating to eyes, but is unlikely to
cause anything more than mild
discomfort which should disappear once product is removed.
LO